Pharmaceutical Strategies, 447 Main St, Stoneham, MA 02180, US

Celgene Avilomics Research is a global biopharmaceutical company headquartered in Cambridge, MA. They are dedicated to pioneering innovations in cancer treatments and transforming the lives of patients. With a focus on research and development, they explore the potential of early discoveries in various platforms and modalities, including cell therapy, to advance the field of medicine and provide better outcomes for patients. Committed to global inclusion and diversity, Celgene Avilomics Research values the contributions of individuals from diverse backgrounds and perspectives. They strive to close the diversity gap in clinical trials and promote the inclusion of underrepresented groups. Through their dedication to scientific research and their focus on patient-centric approaches, Celgene Avilomics Research is at the forefront of advancing cancer treatments and improving survivorship worldwide.Generated from the website